Gepke Visser

6.3k total citations
109 papers, 3.6k citations indexed

About

Gepke Visser is a scholar working on Clinical Biochemistry, Molecular Biology and Physiology. According to data from OpenAlex, Gepke Visser has authored 109 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Clinical Biochemistry, 40 papers in Molecular Biology and 36 papers in Physiology. Recurrent topics in Gepke Visser's work include Metabolism and Genetic Disorders (62 papers), Glycogen Storage Diseases and Myoclonus (23 papers) and Mitochondrial Function and Pathology (21 papers). Gepke Visser is often cited by papers focused on Metabolism and Genetic Disorders (62 papers), Glycogen Storage Diseases and Myoclonus (23 papers) and Mitochondrial Function and Pathology (21 papers). Gepke Visser collaborates with scholars based in Netherlands, United States and United Kingdom. Gepke Visser's co-authors include Kurt Ullrich, Philippe Labrune, James V. Leonard, Jan Peter Rake, Gerrit Smit, Ronald J. A. Wanders, Frits A. Wijburg, Peter Smit, Monique G.M. de Sain–van der Velden and Peter M. van Hasselt and has published in prestigious journals such as Blood, PLoS ONE and American Journal of Clinical Nutrition.

In The Last Decade

Gepke Visser

107 papers receiving 3.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gepke Visser Netherlands	30	1.5k	1.3k	1.2k	925	891	109	3.6k
René Santer Germany	36	925 0.6×	2.3k 1.8×	1.7k 1.4×	850 0.9×	969 1.1×	145	5.1k
Sarah P. Young United States	35	1.1k 0.7×	1.2k 1.0×	388 0.3×	508 0.5×	2.1k 2.4×	105	3.8k
Johan L.K. Van Hove United States	32	466 0.3×	2.2k 1.8×	2.0k 1.7×	455 0.5×	732 0.8×	93	3.8k
Eileen P. Treacy Ireland	31	566 0.4×	1.2k 1.0×	1.4k 1.2×	400 0.4×	522 0.6×	102	2.6k
William J. Rhead United States	36	560 0.4×	2.5k 2.0×	2.6k 2.2×	370 0.4×	1.3k 1.5×	111	4.5k
Joe T.R. Clarke Canada	32	431 0.3×	1.1k 0.9×	537 0.5×	210 0.2×	1.5k 1.7×	109	2.8k
Toshihiro Ohura Japan	27	691 0.5×	1.5k 1.1×	1.8k 1.5×	305 0.3×	654 0.7×	90	3.0k
Viktor Kožich Czechia	36	2.0k 1.4×	1.4k 1.1×	1.2k 1.0×	304 0.3×	450 0.5×	137	3.7k
Helena Stibler Sweden	38	361 0.2×	2.3k 1.8×	366 0.3×	237 0.3×	733 0.8×	95	4.1k
Ute Spiekerkoetter Germany	30	483 0.3×	1.5k 1.2×	1.7k 1.4×	278 0.3×	787 0.9×	111	2.6k

Countries citing papers authored by Gepke Visser

Since Specialization

Citations

This map shows the geographic impact of Gepke Visser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gepke Visser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gepke Visser more than expected).

Fields of papers citing papers by Gepke Visser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gepke Visser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gepke Visser. The network helps show where Gepke Visser may publish in the future.

Co-authorship network of co-authors of Gepke Visser

This figure shows the co-authorship network connecting the top 25 collaborators of Gepke Visser. A scholar is included among the top collaborators of Gepke Visser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gepke Visser. Gepke Visser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pastoret, Cédric, Jun Yang, David J. Feith, et al.. (2025). Diagnostic criteria for NK cell large granular lymphocyte leukemia: validation through a multicentric international study. Blood Advances. 10(3). 642–653.

Sikkema‐Raddatz, Birgit, Terry G. J. Derks, Clara D.M. van Karnebeek, et al.. (2024). Newborn Screening by DNA-First: Systematic Evaluation of the Eligibility of Inherited Metabolic Disorders Based on Treatability. International Journal of Neonatal Screening. 11(1). 1–1. 2 indexed citations

Dijk, Tessa van, et al.. (2023). A qualitative study on the perspectives of mothers who had been diagnosed with primary carnitine deficiency through newborn screening of their child. Orphanet Journal of Rare Diseases. 18(1). 134–134. 1 indexed citations

Ferdinandusse, Sacha, Saskia N. van der Crabben, Eugènie Dekkers, et al.. (2023). Newborn screening for primary carnitine deficiency: who will benefit? – a retrospective cohort study. Journal of Medical Genetics. 60(12). 1177–1185. 7 indexed citations

Weeghel, Michel van, Mayte Suárez‐Fariñas, Carmen Argmann, et al.. (2021). Dietary restriction in the long-chain acyl-CoA dehydrogenase knockout mouse. Molecular Genetics and Metabolism Reports. 27. 100749–100749. 1 indexed citations

Knottnerus, Suzan J. G., Isabella Mengarelli, Rob C. I. Wüst, et al.. (2020). Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Can Be Improved by Lowering Accumulation of Fatty Acid Oxidation Intermediates. International Journal of Molecular Sciences. 21(7). 2589–2589. 24 indexed citations

Mosca, Rosario, Diantha van de Vlekkert, Yvan Campos, et al.. (2020). Conventional and Unconventional Therapeutic Strategies for Sialidosis Type I. Journal of Clinical Medicine. 9(3). 695–695. 15 indexed citations

Knottnerus, Suzan J. G., Henk Schierbeek, Jeannette C. Bleeker, et al.. (2020). Exploring the metabolic fate of medium-chain triglycerides in healthy individuals using a stable isotope tracer. Clinical Nutrition. 40(3). 1396–1404. 11 indexed citations

Knottnerus, Suzan J. G., Mia L. Pras‐Raves, Maria van der Ham, et al.. (2020). Prediction of VLCAD deficiency phenotype by a metabolic fingerprint in newborn screening bloodspots. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1866(6). 165725–165725. 13 indexed citations

10.

Bleeker, Jeannette C., Sacha Ferdinandusse, Maaike de Vries, et al.. (2019). Proposal for an individualized dietary strategy in patients with very long‐chain acyl‐CoA dehydrogenase deficiency. Journal of Inherited Metabolic Disease. 42(1). 159–168. 18 indexed citations

11.

Bosch, Annet M., Margot F. Mulder, M. Estela Rubio‐Gozalbo, et al.. (2019). A nationwide retrospective observational study of population newborn screening for medium‐chain acyl‐CoA dehydrogenase (MCAD) deficiency in the Netherlands. Journal of Inherited Metabolic Disease. 42(5). 890–897. 22 indexed citations

12.

Renkema, G. Herma, Gepke Visser, Fabian Baertling, et al.. (2017). Mutated PET117 causes complex IV deficiency and is associated with neurodevelopmental regression and medulla oblongata lesions. Human Genetics. 136(6). 759–769. 27 indexed citations

13.

Monroe, Glen R., G. W. J. Frederix, Sanne M. C. Savelberg, et al.. (2016). Effectiveness of whole-exome sequencing and costs of the traditional diagnostic trajectory in children with intellectual disability. Genetics in Medicine. 18(9). 949–956. 125 indexed citations

14.

Velden, Monique G.M. de Sain–van der, Maria van der Ham, Judith Jans, et al.. (2016). A New Approach for Fast Metabolic Diagnostics in CMAMMA. JIMD Reports. 30. 15–22. 5 indexed citations

15.

Visser, Gepke, Joep Schmitz, Rutger A. J. Nievelstein, et al.. (2016). Altered Energetics of Exercise Explain Risk of Rhabdomyolysis in Very Long-Chain Acyl-CoA Dehydrogenase Deficiency. PLoS ONE. 11(2). e0147818–e0147818. 33 indexed citations

16.

Waterham, Hans R., et al.. (2014). Hereditaire fructose-intolerantie. Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank. 158. 1 indexed citations

17.

Smit, Gerrit, Maaike de Vries, Johannis B.C. de Klerk, et al.. (2012). Risk stratification by residual enzyme activity after newborn screening for medium-chain acyl-CoA dehyrogenase deficiency: data from a cohort study. Orphanet Journal of Rare Diseases. 7(1). 30–30. 24 indexed citations

18.

Labrune, Philippe, Kurt Ullrich, Peter Smit, et al.. (2002). Guidelines for management of glycogen storage disease type I - European Study on Glycogen Storage Disease Type I (ESGSD I). European Journal of Pediatrics. 161(0). S112–S119. 120 indexed citations

19.

Verhoeven, Arthur J., et al.. (1999). A Convenient Diagnostic Function Test of Peripheral Blood Neutrophils in Glycogen Storage Disease Type Ib. Pediatric Research. 45(6). 881–885. 21 indexed citations

20.

Niezen‐Koning, Klary E., Ronald J. A. Wanders, Jos P.N. Ruiter, et al.. (1997). Succinyl-CoA:acetoacetate transferase deficiency: identification of a new patient with a neonatal onset and review of the literature. European Journal of Pediatrics. 156(11). 870–873. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact